Dr. Otmar Lienhart is an expert in regulatory affairs in the IVD sector with a focus on performance evaluation and post-market surveillance in accordance with the IVDR. He brings broad industry experience from positions in regulatory affairs, quality management and product safety at companies in the pharmaceutical and diagnostics sectors. His expertise is grounded in a doctorate in biology from Albert-Ludwigs-Universität Freiburg.
